Transcriptional regulation of the beta-globin locus is a historically important system for the study of tissue and developmentally regulated transcription in mammals. In addition to its importance for fundamental insights into mammalian transcription, understanding how this locus is regulated holds the potential for developing novel therapies for sickle cell anemia and beta-thalassemia, two very common human genetic disorders. Regulation of the beta-globin locus is analyzed predominantly in transgenic mice that carry transgenes from the human beta-globin locus. This system has been productive but suffers from problems that are inherent to studying human transgenes in mice, where the randomly generated integration site has powerful effects and the murine transcription factors have not coevolved with the cis regulatory elements of the transgene. Results from human locus transgenes have been complemented and clarified by analysis of the murine beta-like globin locus through mutation of the murine locus using homologous recombination in ES cells. Comparisons of the human transgene studies and the murine locus studies have formed a baseline of definitive studies that underlies general conclusions concerning the regulation of this locus regardless of species. ? This proposal continues with the mutational analysis of the routine beta-like globin locus and definitively tests the following hypotheses that have been suggested by studies of human beta-globin locus transgenes in transgenic mice:
Aim l tests the hypothesis that expression of one gene at the locus quantitatively suppresses expression of another gene at the locus which is expressed at the same developmental stage. This will clarify specific aspects of models of how the locus control region influences gene expression.
Aim 2 tests the hypothesis that expression of the embryonic genes suppresses expression of the fetal/adult genes in the embryo. This will prove or disprove the consensus hypothesis concerning the mechanism by which the genes expressed later in development are kept silent early in development.
Aim 3 tests the hypothesis that deletion of the core part of a hypersensitive site in the locus control region will have stronger suppressive effects than deletion of the entire site. Unexpected findings using human transgenes have suggested this hypothesis and the experiments proposed in aim 3 will demonstrate the generality of this hypothesis and develop a facile system to dissect the effect if it is also seen in the murine locus. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054071-07
Application #
6757267
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1997-09-12
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
7
Fiscal Year
2004
Total Cost
$244,902
Indirect Cost
Name
Dartmouth College
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Fromm, George; Cadiz-Rivera, Brenda; de Vries, Christina et al. (2011) An embryonic stage-specific enhancer within the murine ?-globin locus mediates domain-wide histone hyperacetylation. Blood 117:5207-14
Coon, Charles I; Fiering, Steven; Gaudet, Justin et al. (2009) Site controlled transgenic mice validating increased expression from human matrix metalloproteinase (MMP-1) promoter due to a naturally occurring SNP. Matrix Biol 28:425-31
Lathrop, Melissa J; Hsu, Mei; Richardson, Christine A et al. (2009) Developmentally regulated extended domains of DNA hypomethylation encompass highly transcribed genes of the human beta-globin locus. Exp Hematol 37:807-813.e2
Hsu, Mei; Mabaera, Rodwell; Lowrey, Christopher H et al. (2007) CpG hypomethylation in a large domain encompassing the embryonic beta-like globin genes in primitive erythrocytes. Mol Cell Biol 27:5047-54
Hu, Xiao; Eszterhas, Susan; Pallazzi, Nicolas et al. (2007) Transcriptional interference among the murine beta-like globin genes. Blood 109:2210-6
Hu, Xiao; Bulger, Michael; Bender, M A et al. (2006) Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes. Blood 107:821-6
Eszterhas, Susan K; Bouhassira, Eric E; Martin, David I K et al. (2002) Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position. Mol Cell Biol 22:469-79
Bender, M A; Roach, J N; Halow, J et al. (2001) Targeted deletion of 5'HS1 and 5'HS4 of the beta-globin locus control region reveals additive activity of the DNaseI hypersensitive sites. Blood 98:2022-7
Bender, M A; Bulger, M; Close, J et al. (2000) Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol Cell 5:387-93
Bender, M A; Mehaffey, M G; Telling, A et al. (2000) Independent formation of DnaseI hypersensitive sites in the murine beta-globin locus control region. Blood 95:3600-4

Showing the most recent 10 out of 11 publications